PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $105,000 | +105.9% | 35,915 | +100.4% | 0.00% | +100.0% |
| Q1 2020 | $51,000 | -44.6% | 17,920 | -38.9% | 0.00% | -50.0% |
| Q2 2019 | $92,000 | -78.9% | 29,324 | -75.0% | 0.00% | -77.8% |
| Q1 2019 | $437,000 | +97.7% | 117,379 | +310.1% | 0.01% | +28.6% |
| Q4 2014 | $221,000 | – | 28,621 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |